Causal association between cannabis and psychosis: Examination of the evidence

British Journal of Psychiatry

Volumn 184, Issue FEB., 2004, Pages 110-117

  Arseneault, Louise ^a   Cannon, Mary ^a   Witton, John ^a   Murray, Robin M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS ADDICTION; COHORT ANALYSIS; DISEASE ASSOCIATION; HEALTH SERVICE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MENTAL HEALTH; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CANNABIS; HUMANS; PROGNOSIS; PSYCHOTIC DISORDERS; RESEARCH DESIGN; RISK FACTORS; SCHIZOPHRENIA; TIME FACTORS;

EID: 0442307621     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.184.2.110     Document Type: Review

References (44)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: American Psychiatric Assocation.
2. Andrėasson, S., Allebeck, P., Engström, A., et al (1988) Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet, ii, 1483-1485.
3. Arseneault, L., Cannon, M., Poulton, R., et al (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 325, 1212-1213.
4. Boydell, J., van Os, J., Lambri, M., et al (2003) Incidence of schizophrenia in south-east London between 1965 and 1997. British Journal of Psychiatry, 182, 45-49.
5. Cannon, M., Jones, P., Gilvarry, C., et al (1997) Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. American Journal of Psychiatry, 154, 1544-1550.
6. Cannon, M., Caspi, A., Moffitt, T. E., et al (2002) Evidence for early, specific, pan-developmental impairment in schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry, 59, 449-457.
7. Cantwell, R., Brewin, J., Glazebrook, C., et al (1999) Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 174, 150-153.
8. D'Souza, C., Cho, H.-S. Perry, E., et al (2004) A cannabinoid model psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. In Marijuana and Madness (eds D. J. Castle & R. Murray). Cambridge: Cambridge University Press. In press.
9. Duke, P. J., Pantelis, C., McPhillips, M. A., et al (2001) Comorbid non-alcohol substance misuse among people with schizophrenia. Epidemiological study in central London. British Journal of Psychiatry, 179, 509-513.
10. Fergusson, D. M. & Norwood, L. J. (2000) Does cannabis use encourage other forms of illicit drug use? Addiction, 95, 505-520.
11. Fergusson, D. M., Horwood, L. J. & Swain-Campbell, N. R. (2003) Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33, 15-21.
12. Grech, A., Takei, N. & Murray, R. (1998) Comparison of cannabis use in psychotic patients and controls in London and Malta. Schizophrenia Research, 29, 22.
13. Hall, W. & Degenhardt, L. (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34, 26-34.
14. Hall, W. & Degenhardt, L. (2004) Is there a specific 'cannabis psychosis'? In Marijuana and Madness (eds D. J. Castle & R. Murray). Cambridge: Cambridge University Press. In press.
15. Hambrecht, M. & Hafner, H. (1996) Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 1155-1163.
16. Hill, A. B. (1965) The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 58, 295-300.
17. Johns, A. (2001) Psychiatric effects of cannabis. British Journal of Psychiatry, 178, 116-122.
18. Johnston, L. D., O'Malley, P. M. & Bachman, J. G. (2002) Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings 2001 (NIH Publication No. 02-5105). Bethesda, MD: National Institute of Drug Abuse.
19. Jones, P., Rodgers, B., Murray, R., et al (1994) Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398-1402.
20. Kazuo, Y. & Kandel, D. B. (1984) Patterns of drug use from adolescence to young adulthood: II. sequences of progression. American Journal of Public Health, 74, 668-672.
21. Kraemer, H., Stice, E., Kazdin, A., et al (2001) How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158, 848-856.
22. Malmberg, A., Lewis, G., David, A., et al (1998) Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry, 172, 308-313.
23. Mathers, D. C. & Ghodse, A. H. (1992) Cannabis and psychotic illness. British Journal of Psychiatry, 161, 648-653.
24. McCreadie, R. G. (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. British Journal of Psychiatry, 181, 321-325.
25. Menezes, P. R., Johnson, S., Thornicroft, G., et al (1996) Drug and alcohol problems among individuals with severe mental illnesses in south London. British Journal of Psychiatry 168, 612-619.
26. Miller, P., Lawrie, S. M., Hodges, A., et al (2001) Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 36, 338-342.
27. Murray, R., Grech, A., Phillips, P., et al (2003) What is the relationship between substance abuse and schizophrenia? In The Epidemiology of Schizophrenia (eds R. Murray, P. Jones, E. Susser, et al), pp. 317-342. Cambridge: Cambridge University Press.
28. Patton, G. C., Coffrey, C., Carlin, J. B., et al (2002) Cannabis use and mental health in young people: cohort study. BMJ, 325, 1195-1198.
29. Phillips, L. J., Curry, C., Yung, A. R., et al (2002) Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Australian and New Zealand Journal of Psychiatry, 36, 800-806.
30. Poulton, R., Caspi, A., Moffitt, T. E., et al (2000) Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry, 57, 1053-1058.
31. Regier, D., Farmer, M. E., Rae, D. S., et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
32. Robins, L. N. & Regier, D. A. (1991) Psychiatric Disorders in America: the Epidemiologic Catchment Area Study. New York: The Free Press.
33. Rothman, K. J. & Greenland, S. (1998) Modern Epidemiology (2nd edn). Philadelphia, PA: Lippincott-Raven.
34. Silva, P. A. & Stanton, W. R. (1996) From Child to Adult: the Dunedin Multidisciplinary Health and Development Study. Auckland: Oxford University Press.
35. StataCorp (2003) Stata Statistical Software: Release 8.0. Texas: Stata Corporation.
36. Sterne, J. A. C., Bradburn, M. J. & Egger, M. (2001) Meta-analysis in StataTM. In Systematic Review in Health Care: Meta Analysis in Context (eds M. Egger, G. D. Smith & D. G. Attman), pp. 347-369. London: BMJ Books.
37. Susser, M. (1991) What is a cause and how do we know one? A grammar for pragmatic epidemiology. American Journal of Epidemiology, 133, 635-648.
38. Thornicroft, G. (1990) Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 157, 25-33.
39. Tien, A. Y. & Anthony, J. C. (1990) Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease, 178, 473-480.
40. van Os, J., Bak, M., Bijl, R. V., et al (2002) Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology, 156, 319-327.
41. Verdoux, H. (2004) Cannabis and psychosis proneness. In Marijuana and Madness (eds D. J. Castle & R. Murray). Cambridge: Cambridge University Press.
42. Verdoux, H., Gindre, C., Sorbara, F., et al (2003) Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine, 33, 23-32.
43. Wheatley, M. (1998) The prevalence and relevance of substance use in detained schizophrenic patients. Journal of Forensic Psychiatry, 9, 114-129.
44. Zammit, S., Allebeck, P., Andréasson, S., et al (2002) Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. BMJ, 315, 1199-1201.